Related Experiment Video
Updated: Apr 3, 2026

07:32
Standardized Histomorphometric Evaluation of Osteoarthritis in a Surgical Mouse Model
Published on: May 6, 2020
13.5K
METABOLIC BONE CHANGES IN OSTEOARTHRITIS: THE ROLE OF IMAGING AND PATHOGENETIC INTERPRETATION
E Silvestri1, A Corazza2, L Molfetta3
1Department of Radiology and Interventional Ultrasound, Ospedale Evangelico Internazionale (O.E.I.Ge), Genova, Italy.
Journal of Biological Regulators and Homeostatic Agents
|September 26, 2015
Summary
Osteoarthritis, a common joint disease, involves subchondral bone damage. Magnetic resonance imaging is key for diagnosis and understanding disease progression, aiding better treatment outcomes.
Area of Science:
- Rheumatology and Orthopedics
- Medical Imaging
- Biomarkers in Disease
Background:
- Osteoarthritis (OA) is a leading cause of adult disability, characterized by progressive joint degeneration.
- Subchondral bone damage and related biochemical markers are critical indicators in OA pathogenesis.
- Articular cartilage and subchondral bone are key players in the development of osteoarthritis.
Discussion:
- Magnetic resonance (MR) imaging is the optimal technique for detecting and characterizing subchondnal bone abnormalities in OA.
- MR imaging aids in diagnosing, monitoring OA progression, and understanding its natural history.
- Accurate clinical assessment is essential alongside MR imaging to overcome potential diagnostic challenges.
Key Insights:
- Subchondral bone metabolic changes are significant indicators of osteoarthritis.
- MR imaging offers comprehensive insights into OA, from diagnosis to disease understanding.
- Early detection of bone abnormalities via MR can improve OA management.
Outlook:
- Further research into MR techniques may enhance diagnostic accuracy for osteoarthritis.
- Integrating advanced MR imaging with clinical evaluation can optimize patient outcomes.
- Understanding subchondral bone's role in OA pathogenesis is crucial for developing targeted therapies.
Related Concept Videos
Osteoclasts in Bone Remodeling
4.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.8K
Bone Disorders
7.8K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
7.8K
Bone Remodeling
41.1K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
41.1K

